Annette Kristiansen1, Linn Brandt2, Thomas Agoritsas3, Elie A Akl4, Eivind Berge5, Johan Bondi6, Anders E Dahm7, Lars-Petter Granan8, Sigrun Halvorsen9, Pål-Andre Holme7, Anne Flem Jacobsen10, Eva-Marie Jacobsen11, Ignacio Neumann3, Per Morten Sandset12, Torunn Sætre13, Arnljot Tveit14, Trond Vartdal15, Gordon Guyatt3, Per Olav Vandvik16. 1. Department of Internal Medicine, Innlandet Hospital Trust Gjøvik, Institute for Health and Society, University of Oslo, Oslo, Norway; Department of Internal Medicine, Diakonhjemmet Hospital, Oslo, Norway. Electronic address: annettekrist@gmail.com. 2. Department of Internal Medicine, Innlandet Hospital Trust Gjøvik, Institute for Health and Society, University of Oslo, Oslo, Norway; Department of Internal Medicine, Diakonhjemmet Hospital, Oslo, Norway. 3. Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada. 4. Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada; Department of Internal Medicine, American University of Beirut, Beirut, Lebanon. 5. Department of Internal Medicine, Oslo University Hospital, Ullevål, Oslo, Norway. 6. Department of Surgery, Bærum Hospital, Vestre Viken Hospital, Drammen, Norway. 7. Department of Hematology, Oslo University Hospital, Oslo, Norway. 8. Department of Physical Medicine and Rehabilitation, Department of Pain Management and Research, Oslo Sports Trauma Research Center, Norwegian School of Sport Sciences, Oslo University Hospital, Oslo, Norway. 9. Division of Emergencies and Critical Care, Department of Cardiology B, Oslo University Hospital, Oslo, Norway. 10. Department of Internal Medicine, Innlandet Hospital Trust Gjøvik, Institute for Health and Society, University of Oslo, Oslo, Norway. 11. Department of Hematology, Oslo University Hospital, Oslo, Norway; Department of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway. 12. Faculty of Medicine, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Hematology, Oslo University Hospital, Oslo, Norway. 13. Center for Vascular Surgery, Oslo University Hospital, Oslo, Norway. 14. Department of Medical Research, Bærum Hospital, Vestre Viken Hospital, Drammen, Norway. 15. Department of Internal Medicine, Bærum Hospital, Vestre Viken Hospital, Drammen, Norway. 16. Department of Internal Medicine, Innlandet Hospital Trust Gjøvik, Institute for Health and Society, University of Oslo, Oslo, Norway; Norwegian Knowledge Centre for the Health Services, Oslo, Norway.
Abstract
BACKGROUND: Adaptation of guidelines for use at the national or local level can facilitate their implementation. We developed and evaluated an adaptation process in adherence with standards for trustworthy guidelines and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology, aiming for efficiency and transparency. This article is the first in a series describing our adaptation of Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines for a Norwegian setting. METHODS: Informed by the ADAPTE framework, we developed a five-step adaptation process customized to guidelines developed using GRADE: (1) planning, (2) initial assessment of the recommendations, (3) modification, (4) publication, and (5) evaluation. We developed a taxonomy for describing how and why recommendations from the parent guideline were modified and applied a mixed-methods case study design for evaluation of the process. RESULTS: We published the adapted guideline in November 2013 in a novel multilayered format. The taxonomy for adaptation facilitated transparency of the modification process for both the guideline developers and the end users. We excluded 30 and modified 131 of the 333 original recommendations according to the taxonomy and developed eight new recommendations. Unforeseen obstacles related to acquiring a licensing agreement and procuring a publisher resulted in a 9-month delay. We propose modifications of the adaptation process to overcome these obstacles in the future. CONCLUSIONS: This case study demonstrates the feasibility of a novel guideline adaptation process. Replication is needed to further validate the usefulness of the process in increasing the organizational and methodologic efficiency of guideline adaptation.
BACKGROUND: Adaptation of guidelines for use at the national or local level can facilitate their implementation. We developed and evaluated an adaptation process in adherence with standards for trustworthy guidelines and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology, aiming for efficiency and transparency. This article is the first in a series describing our adaptation of Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines for a Norwegian setting. METHODS: Informed by the ADAPTE framework, we developed a five-step adaptation process customized to guidelines developed using GRADE: (1) planning, (2) initial assessment of the recommendations, (3) modification, (4) publication, and (5) evaluation. We developed a taxonomy for describing how and why recommendations from the parent guideline were modified and applied a mixed-methods case study design for evaluation of the process. RESULTS: We published the adapted guideline in November 2013 in a novel multilayered format. The taxonomy for adaptation facilitated transparency of the modification process for both the guideline developers and the end users. We excluded 30 and modified 131 of the 333 original recommendations according to the taxonomy and developed eight new recommendations. Unforeseen obstacles related to acquiring a licensing agreement and procuring a publisher resulted in a 9-month delay. We propose modifications of the adaptation process to overcome these obstacles in the future. CONCLUSIONS: This case study demonstrates the feasibility of a novel guideline adaptation process. Replication is needed to further validate the usefulness of the process in increasing the organizational and methodologic efficiency of guideline adaptation.
Authors: Thomas Agoritsas; Anja Fog Heen; Linn Brandt; Pablo Alonso-Coello; Annette Kristiansen; Elie A Akl; Ignacio Neumann; Kari Ao Tikkinen; Trudy van der Weijden; Glyn Elwyn; Victor M Montori; Gordon H Guyatt; Per Olav Vandvik Journal: BMJ Date: 2015-02-10
Authors: Nicolas Delvaux; Stijn Van de Velde; Bert Aertgeerts; Martine Goossens; Benjamin Fauquert; Ilka Kunnamo; Paul Van Royen Journal: J Eval Clin Pract Date: 2015-08-07 Impact factor: 2.431
Authors: Yang Song; Monica Ballesteros; Jing Li; Laura Martínez García; Ena Niño de Guzmán; Robin W M Vernooij; Elie A Akl; Francoise Cluzeau; Pablo Alonso-Coello Journal: BMJ Open Date: 2021-12-02 Impact factor: 2.692